<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Montalescot, Gilles</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Prehospital Ticagrelor Reduces Stent Thrombosis in STEMI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">17-18</style></pages><abstract><style  face="normal" font="default" size="100%">Administration of ticagrelor in-ambulance resulted in reduced rates of stent thrombosis in patients with STEMI undergoing percutaneous coronary intervention (PCI) compared with patients who received ticagrelor in-hospital; however, the co—primary end points were not achieved. This article presents data from the 30-Day Study to Evaluate Efficacy and Safety of Pre-hospital vs In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for PCI [ATLANTIC; NCT01347580].</style></abstract><number><style face="normal" font="default" size="100%">27</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>